A novel scoring system integrating PBRM1 expression to predict recurrence in patients with non-metastatic clear cell renal cell carcinoma undergoing radical surgery

A novel scoring system integrating PBRM1 expression to predict recurrence in patients with non-metastatic clear cell renal cell carcinoma undergoing radical surgery

Bibliographic Details
Main Authors:	H. Ohsugi, C. Ohe, T. Yoshida, J. Ikeda, H. Kinoshita, T. Matsuda
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320339124

Similar Items

Mutational Analysis of PBRM1 and Significance of PBRM1 Mutation in Anti-PD-1 Immunotherapy of Clear Cell Renal Cell Carcinoma
by: Abudureyimujiang Aili, et al.
Published: (2021-08-01)

Prognostic role of PBRM1 marker expression in clear-cell renal-cell carcinoma
by: D. G. Zaridze, et al.
Published: (2019-04-01)

Characterizing the Mechanism of Tumor Suppression by PBRM1 in Clear Cell Renal Cell Carcinoma
by: Schoenfeld, David Aaron
Published: (2015)

PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma.
by: Basudev Chowdhury, et al.
Published: (2016-01-01)

The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
by: Amrita M. Nargund, et al.
Published: (2017-03-01)

Development and validation of a PBRM1‐associated immune prognostic model for clear cell renal cell carcinoma
by: Jiayi Chen, et al.
Published: (2021-10-01)

Identification of alterations in the nucleotide sequence of the chromatin remodeling gene PBRM1 in clear cell renal cell carcinoma patients
by: E. A. Klimentova, et al.
Published: (2018-11-01)

Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma
by: Svenja Bihr, et al.
Published: (2019-02-01)

Integration of NRP1, RGS5, and FOXM1 expression, and tumour necrosis, as a postoperative prognostic classifier based on molecular subtypes of clear cell renal cell carcinoma
by: Takashi Yoshida, et al.
Published: (2021-11-01)

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
by: Florian Büttner, et al.
Published: (2018-07-01)

PBRM1 Regulates Stress Response in Epithelial Cells
by: Elizabeth G. Porter, et al.
Published: (2019-05-01)

Pure sarcomatous recurrence of clear cell renal carcinoma following radical nephrectomy and dendritic cell vaccination
by: Alberto Azoubel Antunes, et al.

Glycosaminoglycan (GAG) scores for surveillance of recurrence in Leibovich Points ≥5 non-metastatic clear cell renal cell carcinoma: AURORAX-0087A trial in progress report
by: S. Dabestani, et al.
Published: (2020-11-01)

Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
by: Sharon Del Vecchio, et al.
Published: (2018-10-01)

Metastatic clear cell renal cell carcinoma presenting with a gingival metastasis
by: Rusha A.E. Ali, et al.
Published: (2016-06-01)

PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway.
by: HongKai Wang, et al.
Published: (2017-01-01)

Metastatic clear cell renal cell carcinoma to the forearm without identifiable primary renal mass
by: John Walton, et al.
Published: (2019-11-01)

Perineal Metastatic Clear Cell Renal Cell Carcinoma: A Case Report
by: Seung Wook Lee, et al.
Published: (2021-01-01)

Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma
by: I-Jen Chiu, et al.
Published: (2020-03-01)

Clear Cell Adenocarcinoma of the Ureter Similar to Clear Cell Renal Cell Carcinoma Histology
by: Kazuhiro Watanabe, et al.
Published: (2021-01-01)

Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis
by: Judit Espana-Agusti, et al.
Published: (2017-12-01)

Role of PBRM1 in regulation of the HIF pathway
by: Shmakova, Alena
Published: (2016)

Lymph node dissection during radical nephrectomy for clinical node negative, non-metastatic, clear cell renal cell carcinoma: Indications and extent
by: Amod Kumar Dwivedi, et al.
Published: (2011-01-01)

Assessment of survival of patients with metastatic clear cell renal cell carcinoma after radical cytoreductive nephrectomy versus no surgery: a SEER analysis
by: Wen-Jun Xiao, et al.
Published: (2015-04-01)

Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
by: Yoram S. Baum, et al.
Published: (2016-01-01)

Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
by: Nerich V, et al.
Published: (2014-02-01)

Cytodiagnosis of a Cutaneous Clear Cell Malignancy: Metastatic Renal Cell Carcinoma on Chin
by: Anshu Singh, et al.
Published: (2016-01-01)

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
by: Emma Andersson Evelönn, et al.
Published: (2019-01-01)

Current perspectives on systemic therapy for metastatic non-clear cell renal cell carcinoma
by: J. González, et al.
Published: (2020-12-01)

Isolated Metachronic Metastatic Clear Cell Renal Cell Carcinoma in the Thyroid gland 7 Years After Nephrectomy
by: Waniczek Dariusz, et al.
Published: (2013-03-01)

Prognostic value of plasma and urine glycosaminoglycan scores in clear cell renal cell carcinoma
by: Francesco Gatto, et al.
Published: (2016-11-01)

Resolution on the results of the Expert Council on the treatment of advanced and metastatic clear cell renal cell carcinoma
by: Article Editorial
Published: (2019-07-01)

Evaluation of the efficiency of combination palliative treatment in patients with metastatic clear-cell renal cell carcinoma
by: P. S. Borisov, et al.
Published: (2015-09-01)

Rare Presentation of Metastatic Lobular Breast Carcinoma Involving Clear Cell Renal Cell Carcinoma
by: Dayne Ashman, et al.
Published: (2020-01-01)

Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma
by: Tim Eisen, et al.
Published: (2020-11-01)

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
by: Touplikioti Panagiota, et al.
Published: (2009-03-01)

Prognostic value of the ratio of maximum to minimum diameter of primary tumor in metastatic clear cell renal cell carcinoma
by: Cao, C., et al.
Published: (2022)

Significance of preoperative hematologic scoring in predicting death among patients with non-metastatic renal cell carcinoma undergoing nephrectomy
by: Worapat Attawettayanon, et al.
Published: (2021-07-01)

PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth
by: Weijia Cai, et al.
Published: (2019-12-01)

Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC
by: Sai Krishnaraya Doppalapudi, et al.
Published: (2021-08-01)